%0 Journal Article %J Transpl Int %D 1995 %T Inability of OKT3 to prevent donor-derived ABO hemolytic anemia in a kidney-pancreas transplant recipient %A Doutrelepont,J. M. %A Abramowicz,D. %A Lambermont,M. %A Kinnaert,P. %A Vanherweghem,J. L. %A Vereerstraeten,P. %A Goldman,M. %A De Pauw,L. %K Adult %K Anemia, Hemolytic / *etiology / prevention & control %K Female %K Graft Rejection / prevention & control %K Humans %K Kidney Transplantation / *adverse effects %K Male %K Muromonab-CD3 / *administration & dosage %K Pancreas Transplantation / *adverse effects %B Transpl Int %7 34700 %V 8 %P 159 - 60 %G eng %N 2 %M 7766300